Site Search

Share

X

Search Results

ACS CAN Florida Advocacy Hub

... cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of Floridians impacted by cancer and their leadership is vital to defeating this disease. ... Cancer Society Cancer Action Network (ACS CAN) will work with the Florida Legislature on initiatives to provide affordable, adequate access to health insurance including Medicaid, and to ensure adequate funding for cancer research, lifesaving cancer screening programs, and comprehensive ...

Thank You to Our 2023 Lights of Hope Sponsors!

... not accomplish the critical cancer advocacy work that we do without the generosity of our sponsors.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Expand Access to Biomarker Testing in Vermont

... are working together to make sure more Vermont residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Meet the Team

... for the American Cancer Society Cancer Action Network. Brian has also led or been a part of coalitions responsible for a number of access to care wins for patients at the state level including Biomarker Testing Coverage legislation in both Arizona and New Mexico and Medicaid Expansion in ... can truly make a difference in the lives of those who have been touched by cancer. Taking action to help make real change to increase access to care, improve health equity and support cancer research is my personal mission so that all people who hear the words, “You have cancer”, have hope.   Amy ...

Expand Access to Biomarker Testing in Maine

... are working together to make sure more Maine residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Expand Access to Biomarker Testing in Delaware

... more Delaware residents can benefit from this important testing!  Video of maggies_biomarker_story   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

Expand Access to Biomarker Testing in New Hampshire

... are working together to make sure more New Hampshire residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

The Budget & Appropriations Process

... and U.S. Senate begin the process of determining the specifics of how the money will be spent. How much will be spent on education? How much on health care? How much on transportation? This is called the appropriations process since Congress is "appropriating" money to different departments and ...

Federal Budget Process

... and U.S. Senate begin the process of determining the specifics of how the money will be spent. How much will be spent on education? How much on health care? How much on transportation? This is called the appropriations process since Congress is "appropriating" money to different departments and ...

Sandra Cassese, MSN, RN, CNS, Immediate Past Chair of the Board

... mammography screening rates for minority women in Dutchess County. She also serves on the Board of Directors for The Hospice and Palliative Care Association of New York State. Ms. Cassese earned her Nursing Diploma from The Charles E. Gregory School of Nursing, a Bachelor's degree in Nursing from The State University of New York at New Paltz, and a Master's degree in Community Health from Sage Graduate School.   She is the President and Chief Operating Officer for Hospice of Orange & Sullivan Counties in New York’s ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy